The miR-200 Family Controls -Tubulin III Expression and Is Associated With Paclitaxel-Based Treatment Response and Progression-Free Survival in Ovarian Cancer Patients

Endocrine-Related Cancer - United Kingdom
doi 10.1677/erc-10-0148
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Hypermethylation of the microRNA miR-124, miR-125b, miR-127, and miR-129 in Ovarian Carcinoma Is Involved in Suppression of Their Expression and Associated With Both the Development and Progression of Ovarian Cancer

Almanac of Clinical Medicine
2019English

hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance

Journal of Cancer Therapy
2016English

Ovarian Cancer Cell Invasiveness Is Associated With Discordant Exosomal Sequestration of Let-7 miRNA and miR-200

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Association of MDM2 Expression With Shorter Progression-Free Survival and Overall Survival in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine-Based Chemotherapy

PLoS ONE
Multidisciplinary
2017English

Prognosis and Conditional Disease-Free Survival Among Patients With Ovarian Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Increased Expression of H-Prune Is Associated With Tumor Progression and Poor Survival in Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2007English

P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2019English

Metformin Intake Is Associated With Better Survival in Ovarian Cancer

Cancer
Cancer ResearchOncology
2012English

Overexpression of Class III Β-Tubulin, Sox2, and Nuclear Survivin Is Predictive of Taxane Resistance in Patients With Stage III Ovarian Epithelial Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy